magnesium isoglycyrrhizinate

Small moleculeexperimental

Clinical trial activity

6 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
3

Earliest trial started Dec 1, 2007 (NCT02734966)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • 18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-o-beta-d-glucopyranurosyl-alpha-d-glucopyranosiduronate magnesium tetrahydrate
  • magnesium isoglycyrrhizinate
  • magnesium isoglycyrrhizinate
  • magnesium isoglycyrrhizinate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06922669N/AJun 24, 2025Government of China, Huazhong University of Science and Technology, People's Liberation Army of China, Shandong University, Tianjin Medical University
NCT04595916Phase 4Apr 4, 2020Haisco Pharmaceutical, Jiao Tong University
NCT03349008Phase 4Nov 25, 2017Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT03813914N/AJan 15, 2017University of Messina
NCT01802996Phase 4Mar 1, 2013Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd, People's Liberation Army of China
NCT02734966Phase 2Dec 1, 2007Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd, Jiao Tong University
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,LtdFor profit3322007
Jiao Tong UniversityAcademic/Hospital2022007
People's Liberation Army of ChinaGovernment2122013
Government of ChinaGovernment1012025
Haisco PharmaceuticalFor profit1112020
Huazhong University of Science and TechnologyAcademic/Hospital1012025
Shandong UniversityAcademic/Hospital1012025
Tianjin Medical UniversityAcademic/Hospital1012025
University of MessinaAcademic/Hospital1112017
9 organizations
Page 1 / 1